Should you buy National HealthCare (NHC)?
Updated
National HealthCare Corporation is a medical care facilities operator with a strong Piotroski F-Score of 8 and solid free cash flow quality, but cyclical earnings risk is extreme — the forward P/E stands at 455x versus trailing 25x, implying a near-total earnings collapse ahead — making this a hold-only situation at current near-52-week-high prices.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.
What the engine is tracking
| Pillar | Expectation | Trend |
|---|---|---|
The forward P/E of 455x versus the trailing P/E of 25x implies analysts forecast earnings to decline by approximately 95% from their current level, representing one of the starkest cyclical trap warnings in the screening universe. Bear case | Earnings do not decline as severely as forecasts suggest, and forward P/E compresses below 50x within 12 months through actual earnings delivery above consensus. | →Stable |
| CounterA dramatic forward earnings decline may reflect known one-time items in trailing results, and normalized earnings power could be considerably higher than the forward consensus indicates. | ||
Despite cyclical earnings risk, National HealthCare scores 8 out of 9 on the Piotroski scale and generates a FCF quality score of 6.8, indicating broad balance-sheet health and reasonable cash conversion quality. Quality breakdown | Piotroski F-Score remains at 7 or above and free cash flow quality score stays above 5.0 over the next 12 months. | →Stable |
| CounterA strong Piotroski score based on historical financials may not fully reflect forward earnings deterioration; historical strength does not guarantee future resilience through a cyclical down period. | ||
Historical earnings data shows the company missed estimates in all 4 available prior quarterly comparisons with an average negative surprise of -9%, suggesting a pattern of disappointing relative to analyst forecasts. Earnings | The company meets or beats consensus EPS in at least 2 of the next 4 quarters, demonstrating improved forecasting accuracy. | →Stable |
| CounterEarnings miss patterns in healthcare operators can reflect conservative analyst modeling rather than actual underperformance, particularly in businesses with stable government reimbursement contracts. | ||
The forward P/E of 455x versus the trailing P/E of 25x implies analysts forecast earnings to decline by approximately 95% from their current level, representing one of the starkest cyclical trap warnings in the screening universe.
→Stable- Expectation
- Earnings do not decline as severely as forecasts suggest, and forward P/E compresses below 50x within 12 months through actual earnings delivery above consensus.
CounterA dramatic forward earnings decline may reflect known one-time items in trailing results, and normalized earnings power could be considerably higher than the forward consensus indicates.
Despite cyclical earnings risk, National HealthCare scores 8 out of 9 on the Piotroski scale and generates a FCF quality score of 6.8, indicating broad balance-sheet health and reasonable cash conversion quality.
→Stable- Expectation
- Piotroski F-Score remains at 7 or above and free cash flow quality score stays above 5.0 over the next 12 months.
CounterA strong Piotroski score based on historical financials may not fully reflect forward earnings deterioration; historical strength does not guarantee future resilience through a cyclical down period.
Historical earnings data shows the company missed estimates in all 4 available prior quarterly comparisons with an average negative surprise of -9%, suggesting a pattern of disappointing relative to analyst forecasts.
→Stable- Expectation
- The company meets or beats consensus EPS in at least 2 of the next 4 quarters, demonstrating improved forecasting accuracy.
CounterEarnings miss patterns in healthcare operators can reflect conservative analyst modeling rather than actual underperformance, particularly in businesses with stable government reimbursement contracts.
▸ Show 1 more pillar▾ Show fewer
The stock is trading within 5% of its 52-week high with a golden cross technical setup and MACD bullish, but volume distribution is falling — suggesting weakening institutional participation at elevated price levels near the high.
→Stable- Expectation
- Price sustains above $185 over the next 3 months and volume distribution reverses to net accumulation.
CounterNear-52-week-high setups in healthcare utilities can signal continued momentum rather than distribution, particularly when macro conditions favor defensive sectors.
→ Full pillar scorecard with all 4 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1The forward P/E of 455x versus the trailing P/E of 25x implies analysts forecast earnings to decline by approximately 95% from their current level, representing one of the starkest cyclical trap warnings in the screening universe.
Trip ifForward P/E rises above 600x or annual EPS declines more than 70% from the most recently reported trailing figure.
- P2Despite cyclical earnings risk, National HealthCare scores 8 out of 9 on the Piotroski scale and generates a FCF quality score of 6.8, indicating broad balance-sheet health and reasonable cash conversion quality.
Trip ifPiotroski F-Score falls below 6 or free cash flow quality score drops below 4.0.
- P3Historical earnings data shows the company missed estimates in all 4 available prior quarterly comparisons with an average negative surprise of -9%, suggesting a pattern of disappointing relative to analyst forecasts.
Trip ifEPS surprise falls below -15% in at least 3 of the next 4 quarters.
- P4The stock is trading within 5% of its 52-week high with a golden cross technical setup and MACD bullish, but volume distribution is falling — suggesting weakening institutional participation at elevated price levels near the high.
Trip ifPrice drops below $183 stop-loss level or on-balance volume declines for more than 6 consecutive weeks.
How the engine reached this verdict
TrendMatrix's engine output for National HealthCare Corporation (NHC) is SELL_IF_HOLDING with high conviction, score 4.3/10 at $200.83. The F-path SELL output reflects an overall score of 2.8 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. Asymmetry R:R of 0.00 is supplementary context, not the trigger.
SELL output reflects multiple gate failures; recovery requires a confluence of those gates re-clearing, not a single dimension move.
On the bear side: Earnings expected to decline ~95% (cyclical peak); Near 52-week high (1.9% away); Leverage penalty (D/E 3.6): -1.5. Active engine warnings: V8: Cyclical trap - fwd PE 472x vs trail 26x (18.3x).
The engine's exit framework anchors to a tactical sell band near $200.83, with structural invalidation at $187.91. The asymmetric R:R against a reversal hypothesis is -0.01 — the upside scenario exists, but it requires multiple structural gates to flip; the downside scenario requires only one more disappointment. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates NHC — 10-dimension breakdown →
Bear case
- ▸Earnings expected to decline ~95% (cyclical peak)
- ▸Near 52-week high (1.9% away)
- ▸Leverage penalty (D/E 3.6): -1.5